Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypercalcemia revealing diffuse granulomatous myositis

Weniko Caré1, Estelle Blanc2, Jean-Marie Cournac3

  • 1Hopital d'Instruction des Armées Percy, Clamart, Ile-de-France, France. weniko_care@hotmail.com.

European Journal of Nuclear Medicine and Molecular Imaging
|April 12, 2017
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The temporal gene expression landscape of rhabdomyolysis-induced acute kidney injury reveals the timing of complement activation.

Communications biology·2025
Same author

The risk of secondary exposure in the operating room from a sulfur mustard-contaminated penetrating wound using a simulation scenario.

Clinical toxicology (Philadelphia, Pa.)·2025
Same author

Adverse reactions of liquorice consumed in the diet: a 10-year retrospective study of poison centres in France.

Clinical toxicology (Philadelphia, Pa.)·2025
Same author

Sea Anemone Sting.

The New England journal of medicine·2025
Same author

Identification of 4F-MDMB-BICA using a molecular network strategy in a case of severe poisoning with coma.

Journal of analytical toxicology·2025
Same author

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.

Lancet (London, England)·2025